HealthEquity (HQY) last issued guidance on March 17, 2026 for fiscal year 2027. The company guided earnings per share in the range of $4.56 - $4.65, compared to a consensus EPS estimate of $4.26. HealthEquity also guided revenue in the range of $1.41B - $1.42B for the period.
Compared to prior guidance, HealthEquity raised its revenue forecast from a prior range of $1.38B - $1.41B.
HealthEquity has issued 24 guidance updates between June 6, 2022 and March 17, 2026. During this period, the company raised its outlook 16 times, reflecting management's growing confidence in business performance.
Review all historical guidance issued by HealthEquity, including EPS and revenue forecasts across quarterly and annual periods.
The most recent guidance for HealthEquity (HQY) was reported on March 17, 2026 for the fiscal year 2027. The company provided earnings per share guidance in the range of $4.56 to $4.65, compared to the estimated EPS of $4.26. Additionally, HealthEquity forecasted revenue between $1.41B and $1.42B for the period.
HealthEquity (HQY) guided EPS in the range of $4.56 to $4.65 for the fiscal year 2027. The consensus analyst EPS estimate is $4.26.
HealthEquity (HQY) guided revenue in the range of $1.41B to $1.42B for the fiscal year 2027.
HealthEquity (HQY) raised its revenue guidance from a prior range of $1.38B - $1.41B to $1.41B - $1.42B for the fiscal year 2027.
HealthEquity (HQY) last issued guidance on March 17, 2026 for the fiscal year 2027.